About The Medical Condition MDL17,043
Find the definition of the medical term MDL17,043. MDL17,043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
MDL17,043
| MDL17,043 Medical Condition |
|---|
What's The Definition Of The Medical Condition MDL17,043?
1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Focal Epilepsies ‐ Conditions characterized by recurrent paroxysmal neuronal discharges…
- Kallikrein A ‐ Proteolytic enzymes from the serine endopeptidase family found…
- Laboratory Technicians ‐ Those health care professionals, technicians, and assistants…
- Cystostomies, Suprapubic ‐ Surgical creation of an opening (stoma) for drainage of the urinary…
- Propyl Alcohol ‐ A colorless liquid made by oxidation of aliphatic hydrocarbons…
- Exertional Headache, Benign ‐ Common conditions characterized by persistent or recurrent headaches…
- School, Health Occupations ‐ Schools which offer training in the area…
- Tic Disorder, Childhood ‐ Disorders characterized by recurrent TICS that may interfere…
- Valve Regurgitation, Pulmonary ‐ Backflow of blood from the pulmonary artery into the right ventricle,…
- Ulna Fracture ‐ Fractures of the larger bone of…